 Cholangiocarcinoma (CCA) relatively rare type primary liver cancer originates bile duct epithelium. aggressive malignancy typified unresponsiveness chemotherapy radiotherapy. Despite advances radiologic techniques laboratory diagnostic test, diagnosis CCA remains highly challenging. Development molecular techniques led go possible use serum markers diagnosing cholangiocarcinoma. review summarizes principal characteristics serum markers cholangiocarcinoma. tumour markers used frequently Carbohydrate antigen 19-9 (CA 19-9), Carcinogenic Embryonic antigen (CEA), Cancer Antigen 125 shown sufficient sensitivity specificity detect monitor CCA. particular, combination tumour markers seems increase efficiency diagnosing cholangiocarcinoma. New markers Soluble fragment cytokeratin 19 (CYFRA 21-1) Mucins, Tumour Markers<formula>_{2}</formula> pyruvate-Kinase (TuM<formula>_{2-}</formula> PK) metalloproteinase-7 (MMP-7) recently shown help diagnosis CCA, cases prognostic value.